Donald R. Conklin, president of Schering-Plough Pharmaceuticals, a unit of Schering-Plough Corp., and Barry M. Bloom, retired executive vice president for research at Pfizer Inc., were named directors of this biotechnology company.
Mr. Conklin is also a director of Schering.
The new appointments by Vertex increase the size of its board to seven directors.
